Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors
- PMID: 9374462
- DOI: 10.1126/science.278.5343.1623
Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors
Abstract
A lymphocyte subpopulation, the Valpha14 natural killer T (NKT) cells, expresses both NK1.1 and a single invariant T cell receptor encoded by the Valpha14 and Jalpha281 gene segments. Mice with a deletion of the Jalpha281 gene segment were found to exclusively lack this subpopulation. The Valpha14 NKT cell-deficient mice could no longer mediate the interleukin-12 (IL-12)-induced rejection of tumors. Although the antitumor effect of IL-12 was thought to be mediated through natural killer cells and T cells, Valpha14 NKT cells were found to be an essential target of IL-12, and they mediated their cytotoxicity by an NK-like effector mechanism after activation with IL-12.
Similar articles
-
The regulatory role of Valpha14 NKT cells in innate and acquired immune response.Annu Rev Immunol. 2003;21:483-513. doi: 10.1146/annurev.immunol.21.120601.141057. Epub 2001 Dec 19. Annu Rev Immunol. 2003. PMID: 12543936 Review.
-
Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells.Int J Cancer. 2001 Feb 15;91(4):523-8. doi: 10.1002/1097-0215(20010215)91:4<523::aid-ijc1087>3.0.co;2-l. Int J Cancer. 2001. PMID: 11251976
-
Recognition and function of Valpha14 NKT cells.Semin Immunol. 2000 Dec;12(6):543-50. doi: 10.1006/smim.2000.0270. Semin Immunol. 2000. PMID: 11145860 Review.
-
Differential tumor surveillance by natural killer (NK) and NKT cells.J Exp Med. 2000 Feb 21;191(4):661-8. doi: 10.1084/jem.191.4.661. J Exp Med. 2000. PMID: 10684858 Free PMC article.
-
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.Proc Natl Acad Sci U S A. 1998 May 12;95(10):5690-3. doi: 10.1073/pnas.95.10.5690. Proc Natl Acad Sci U S A. 1998. PMID: 9576945 Free PMC article.
Cited by
-
A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers.Front Immunol. 2024 Feb 29;15:1362775. doi: 10.3389/fimmu.2024.1362775. eCollection 2024. Front Immunol. 2024. PMID: 38487528 Free PMC article. Clinical Trial.
-
NKT cells in the antitumor response: the β version?J Clin Invest. 2024 Feb 15;134(4):e177663. doi: 10.1172/JCI177663. J Clin Invest. 2024. PMID: 38357925 Free PMC article.
-
Enhancement of Macrophage Immunity against Chlamydial Infection by Natural Killer T Cells.Cells. 2024 Jan 11;13(2):133. doi: 10.3390/cells13020133. Cells. 2024. PMID: 38247825 Free PMC article.
-
Unique adipose tissue invariant natural killer T cell subpopulations control adipocyte turnover in mice.Nat Commun. 2023 Dec 21;14(1):8512. doi: 10.1038/s41467-023-44181-3. Nat Commun. 2023. PMID: 38129377 Free PMC article.
-
Intrinsic factors and CD1d1 but not CD1d2 expression levels control invariant natural killer T cell subset differentiation.Nat Commun. 2023 Dec 1;14(1):7922. doi: 10.1038/s41467-023-43424-7. Nat Commun. 2023. PMID: 38040679 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases